【発明の名称】4-アザ-プレグナン5α-レダクターゼアイソザイム1阻害剤

Title:

【発明の名称】4-アザ-プレグナン5α-レダクターゼアイソザイム1阻害剤

Document Type and Number:

Japanese Patent JP3325026

Kind Code:

B2

Abstract:

PCT No. PCT/US94/07220 Sec. 371 Date Oct. 31, 1995 Sec. 102(e) Date Oct. 31, 1995 PCT Filed Jun. 27, 1994 PCT Pub. No. WO95/00147 PCT Pub. Date Jan. 5, 1995Compounds of formula (I), wherein: R1 is selected from the group consisting of hydrogen and methyl; R2 is selected from the group consisting of methyl and ethyl; R3 is selected from the group consisting of hydrogen and methyl; and the C1-C2 carbon-carbon bond may be a single or double bond. Such compounds are useful in the treatment of pathologic conditions that benefit from blockade of isozymes of 5 alpha -reductase. (I)

Inventors:

Deilette, Firitpe El
Satsho, Samya Pee

Application Number:

JP50311895A

Publication Date:

September 17, 2002

Filing Date:

June 27, 1994

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Merck End Company, Inc.

International Classes:

A61K31/56; A61K31/58; A61P5/28; A61P43/00; C07J7/00; C07J43/00; C07J51/00; C07J73/00; (IPC1-7): C07J43/00

Attorney, Agent or Firm:

Yoshio Kawaguchi (2 outside)

Previous Patent: フッ素化１７β−置換，４−アザ−５α−アンドロスタン−３−オン誘導体

Next Patent: エアバッグ、エアバッグの折畳み法、ならびに該方法を実施するための装�...